RIPE Knowledge Graph
Back to explore

OnabotulinumtoxinA 100 U Significantly Improves All Idiopathic Overactive Bladder Symptoms and Quality of Life in Patients with Overactive Bladder and Urinary Incontinence: A Randomised, Double-Blind, Placebo-Controlled Trial

Catherine Thompson, Christopher Chapple, Christopher Nardo, Cornelia Haag-Molkenteller, Jihao Zhou, Karl-Dietrich Sievert, Piotr Radziszewski, Scott Macdiarmid, Vik Khullar

1 Assessments

0 Serious · 0 Some · 1 No · 0 N/A

ReviewerDateQ1.1Does the study have an associated retraction?Q1.2Does the study have an associated expression of concern or other relevant post-publication notice?Q1.3Do other studies by the research team highlight causes for concern?Q2.2Are there concerns relating to the timing or absence of study registration?OverallActions
RV011

Statistician

17 Nov 2025
No
No
No
No
No concernsView

Publication Details

Journal
European Urology
Publisher
Elsevier BV
Published
10 Apr 2013
Pages
pp. 249–256
ISSN / eISSN
0302-2838
OnabotulinumtoxinA 100 U Significantly Improves All Idiopathic Overactive Bladder Symptoms and Quality of Life in Patients with Overactive Bladder and Urinary Incontinence: A Randomised, Double-Blind, Placebo-Controlled Trial | RIPE Knowledge Graph